Assessment of the Impact of Neocement Inject P® (Beta-Tricalcium Phosphate) on Bone Volume in Alveolar Ridge Preservation After Tooth Extraction

Condition(s) studied

Investigational drug(s) / intervention(s)

Neocement Inject P® (Beta-Tricalcium Phosphate): After tooth extraction the socket will be grafted with Neocement Inject P® (Beta-Tricalcium Phosphate).

Study summary

The goal of this randomized clinical trial is to assess whether β-TCP (Beta-Tricalcium Phosphate) improves alveolar ridge preservation (ARP) in patients who need tooth extraction. The main question it aims to answer is whether using β-TCP for alveolar ridge preservation has a positive effect on bone volume compared with natural healing.

The main questions it aims to answer are:

Does β-TCP improve ridge preservation compared with natural healing?

Researchers will compare β-TCP grafted sockets to natural healing sockets to see if β-TCP better preserves ridge volume.

Participants will:

Have a tooth indicated for extraction.

Be assigned to either β-TCP or natural healing.

Undergo CBCT (Cone Beam Computed Tomography) and intra-oral scanning after extraction and after six months of healing to measure horizontal and vertical resorption and bone density.

Eligibility

Primary outcome measure(s)

• Change in alveolar ridge volume after tooth extraction — From enrollment to the end of treatment at 6 months
  Change in alveolar ridge volume after tooth extraction on sockets grafted with Beta-Tricalcium Phosphate

Trial sites (1)

More Egas Moniz - Cooperativa de Ensino Superior, CRL trials in Portugal

Other trials for the same condition